These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3708119)

  • 1. Bioavailability of seven furosemide tablets in man.
    Straughn AB; Wood GC; Raghow G; Meyer MC
    Biopharm Drug Dispos; 1986; 7(2):113-20. PubMed ID: 3708119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.
    McNamara PJ; Foster TS; Digenis GA; Patel RB; Craig WA; Welling PG; Rapaka RS; Prasad VK; Shah VP
    Pharm Res; 1987 Apr; 4(2):150-3. PubMed ID: 3509139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men.
    Waller ES; Crismon ML; Smith RV; Bauza MT; Doluisio JT
    Biopharm Drug Dispos; 1988; 9(2):211-8. PubMed ID: 3370308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of two furosemide formulations in humans.
    Martin BK; Uihlein M; Ings RM; Stevens LA; McEwen J
    J Pharm Sci; 1984 Apr; 73(4):437-41. PubMed ID: 6726624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
    Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
    J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of an oral frusemide/amiloride combination tablet.
    Brooks SG; Christie RB; Roche J; Fairhead AP; Muirhead D; Townsend HA; Shaw HL
    Curr Med Res Opin; 1984; 9(2):141-6. PubMed ID: 6399890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
    Qureshi SA; McGilveray IJ
    Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.
    Yagi N; Kiuchi T; Satoh H; Terashima Y; Kenmotsu H; Sekikawa H; Takada M
    Biol Pharm Bull; 1996 Apr; 19(4):616-22. PubMed ID: 8860970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioequivalence study of two products of furosemide tablets.
    Awad R; Arafat T; Saket M; Saleh M; Gharaibeh M; Zmeili S; Sallam E; Shubair M; Qobrosi S
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):18-23. PubMed ID: 1551740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations.
    Meyer BH; Müller FO; Hundt HK; Grigoleit HG; Hajdu P; Heptner W
    S Afr Med J; 1981 Jun; 59(25):891-3. PubMed ID: 7015536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.
    Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
    Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans.
    Straughn AB; Wood GC; Raghow G; Meyer MC
    J Pharm Sci; 1985 Mar; 74(3):335-7. PubMed ID: 4009445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.
    Smal J; Marvola M; Liljequist C; Happonen I
    J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.